Table 1 Baseline characteristics and demographics of Italian patients enrolled in the PATRO Children study up to August 2015
Characteristic | N = 186 |
|---|---|
Gender(%) | |
Male | 107 (57.5) |
Female | 79 (42.5) |
Chronological age, years | 10.2 ± 3.3 |
HSDS ± SD | −2.29 ± 0.86 (Nmiss = 30) |
Height velocity, cm/year ± SD | 3.9 ± 2.1 (Nmiss = 91) |
BMI, kg/m2 ± SD | 17.2 ± 3.6 (Nmiss = 35) |
Diagnosis at presentation, n (%) | |
GHD | 156 (84.0) |
SGA | 12 (6.5) |
TS | 3 (1.6) |
PWS | 7 (3.8) |
CRI | 1 (0.5) |
Other | 7 (3.8) |
Previous treatment status, n (%) | |
Hormone naïve | 167 (89.8) |
Pre-treated | 19 (10.2) |
Omnitrope® dosing at baseline, mg/kg/day | 0.032 ± 0.008 |
Duration of Omnitrope® treatment, months | 28.3 ± 19.1 |